Pharmacoepidemiology is an international, peer-reviewed, open access journal on high-quality epidemiological, clinical research across the fields of clinical pharmacology and epidemiology, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • Rapid Publication: first decisions in 16 days; acceptance to publication in 5.8 days (median values for MDPI journals in the first half of 2023).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Pharmacoepidemiology is a companion journal of Pharmaceuticals.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in JCM, Pharmaceuticals, Pharmacoepidemiology, Pharmacy, Vaccines, Healthcare
Mass Vaccination Campaigns: From Post-authorization Benefit-Risk Assessment to Public Health Impact Topic Editors: Giampiero Mazzaglia, Lorenzo Giovanni Mantovani, Ippazio Cosimo Antonazzo
Deadline: 30 November 2023
Topic in Cancers, Healthcare, Pharmaceuticals, Pharmaceutics, Pharmacoepidemiology
Advance in Cancer Pharmacoepidemiology Topic Editors: Shih-Chieh Shao, Edward Chia-Cheng Lai
Deadline: 20 February 2025
Special Issue in Pharmacoepidemiology
Drug Safety and Effectiveness in the Real World Guest Editors: Li-Ting Kao, Yu-Tien Chang, Ke-Ting Pan
Deadline: 30 November 2023
Special Issue in Pharmacoepidemiology
Anti-Infectives: Pharmacoepidemiology and Clinical Pharmacology Guest Editors: Lee Nguyen, Jason Yamaki
Deadline: 25 December 2023
Special Issue in Pharmacoepidemiology
International Pharmacoepidemiology Guest Editor: Edward Lai
Deadline: 31 December 2023
Special Issue in Pharmacoepidemiology
Drug Regulations and Pharmaceutical Safety: Issues and Opportunities Guest Editor: Sanya Ram
Deadline: 1 February 2024
Back to TopTop